Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome

Clinica Chimica Acta

Volumn 446, Issue , 2015, Pages 277-283

  Leon Justel, Antonio ^a   Noval Padillo, Jose A ^b   Alvarez Rios, Ana I ^b   Mellado, Patricia ^b   Gomez Bravo, Miguel A ^b   Álamo, Jose M ^b   Porras, Manuel ^b   Barrero, Lydia ^b   Hinojosa, Rafael ^b   Carmona, Magdalena ^b   Vilches Arenas, Angel ^c   Guerrero, Juan M ^b  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Blood loss; Liver transplantation; Measurement techniques coagulation; Mobile laboratory; Point of care testing

Indexed keywords

FIBRINOGEN; HEMOGLOBIN; TRANEXAMIC ACID;

ACUTE KIDNEY FAILURE; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODYNAMIC STRESS; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PATIENT MONITORING; PLASMA TRANSFUSION; POINT OF CARE TESTING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REOPERATION; THROMBOCYTE TRANSFUSION; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ECONOMICS; HEMORRHAGE; HEMOSTATIC TECHNIQUE; METABOLISM; MIDDLE AGED; PATHOLOGY; POINT OF CARE SYSTEM; RISK; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN; HEMOGLOBINS; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET TRANSFUSION; POINT-OF-CARE SYSTEMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 84929402460     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.04.022     Document Type: Article

References (36)

1. Polak W.G., Soyama A., Slooff M.J. Liver transplantation in patients with hepatocellular carcinoma. Ann Transplant 2008, 13:5-15.
2. Markiewicz-Kijewska M., Szymczak M., Ismail H., et al. Liver transplantation for fulminant Wilson's disease in children. Ann Transplant 2008, 13:28-31.
3. Massicotte L., Sassine M.P., Lenis S., Roy A. Transfusion predictors in liver transplant. Anesth Analg 2004, 98:1245-1251.
4. Massicotte L., Sassine M.P., Lenis S., Seal R.F., Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth 2005, 52:148-155.
5. de Boer M.T., Christensen M.C., Asmussen M., et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008, 106:32-44. [table of contents].
6. Wu S.C., Chen C.L., Wang C.H., et al. Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation. Ann Transplant 2012, 17:64-71.
7. Spiess B.D., Royston D., Levy J.H., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004, 44:1143-1148.
8. Dalmau A., Sabate A., Aparicio I. Hemostasis and coagulation monitoring and management during liver transplantation. Curr Opin Organ Transplant 2009, 14:286-290.
9. Hoffman M., Monroe D.M. A cell-based model of hemostasis. Thromb Haemost 2001, 85:958-965.
10. Porte R.J., Hendriks H.G., Slooff M.J. Blood conservation in liver transplantation: the role of aprotinin. J Cardiothorac Vasc Anesth 2004, 18:31S-37S.
11. Ramos E., Dalmau A., Sabate A., et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003, 9:1320-1327.
12. Coakley M., Reddy K., Mackie I., Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006, 20:548-553.
13. Roullet S., Pillot J., Freyburger G., et al. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. Br J Anaesth 2010, 104:422-428.
14. Neal M.D., Marsh A., Marino R., et al. Massive transfusion: an evidence-based review of recent developments. Arch Surg 2012, 147:563-571.
15. Leon-Justel A., Noval-Padillo J.A., Polonio F., et al. Mobile Laboratory Unit: a disruptor solution for hemostasis management during major surgery. Usage in the context of face transplantation. Clin Chem Lab Med 2012, 50:1621-1624.
16. American Society of Anaesthesiologists ASA guidelines [Accessed August 2012]. http://www.asahq.org/For-Members/Standards-Guidelines-and-Statements.aspx.
17. Kozek-Langenecker S.A., Afshari A., Albaladejo P., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013 Jun, 30(6):270-382.
18. Rahe-Meyer N., Solomon C., Hanke A., et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013, 118:40-50.
19. Görlinger K., Dirkmann D., Hanke A.A. Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol 2013 Apr, 26(2):230-243.
20. Haas T., Goobie S., Spielmann N., et al. Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM(®)-assisted strategy-feasibility and costs. Paediatr Anaesth 2014 Jul, 24(7):774-780.
21. Noval-Padillo J.A., Leon-Justel A., Mellado-Miras P., et al. Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood. Transplant Proc 2010, 42:2973-2974.
22. Massicotte L., Denault A.Y., Beaulieu D., et al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation 2012, 93:1276-1281.
23. Wegner J., Popovsky M.A. Clinical utility of thromboelastography: one size does not fit all. Semin Thromb Hemost 2010, 36:699-706.
24. Feltracco P., Brezzi M., Barbieri S., et al. Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol 2013, 5:1-15.
25. Wang S.C., Shieh J.F., Chang K.Y., et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010, 42:2590-2593.
26. Dalmau A., Sabate A., Koo M., et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 2004, 10:279-284.
27. Frasco P.E., Poterack K.A., Hentz J.G., Mulligan D.C. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005, 101:30-37. [table of contents].
28. Massicotte L., Beaulieu D., Thibeault L., et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008, 85:956-962.
29. Tripodi A., Mannucci P.M. The coagulopathy of chronic liver disease. N Engl J Med 2011, 365:147-156.
30. Massicotte L., Beaulieu D., Roy J.D., et al. MELD score and blood product requirements during liver transplantation: no link. Transplantation 2009, 87:1689-1694.
31. Massicotte L., Capitanio U., Beaulieu D., Roy J.D., Roy A., Karakiewicz P.I. Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation. Transplantation 2009, 88:386-391.
32. Levy J.H., Szlam F., Tanaka K.A., Sniecienski R.M. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012, 114:261-274.
33. Hendriks H.G., van der Meer J., de Wolf J.T., et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005, 17:673-679.
34. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003, 349:931-940.
35. Lewis M.B., Howdle P.D. Neurologic complications of liver transplantation in adults. Neurology 2003, 61:1174-1178.
36. Lentschener C., Roche K., Ozier Y. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects?. Anesth Analg 2005, 100:1248-1255.